Works matching IS 13479032 AND DT 2018 AND VI 109 AND IP 10


Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions.

    Published in:
    Cancer Science, 2018, v. 109, n. 10, p. 3149, doi. 10.1111/cas.13752
    By:
    • Kato, Yuka;
    • Ninomiya, Kiichiro;
    • Ohashi, Kadoaki;
    • Tomida, Shuta;
    • Makimoto, Go;
    • Watanabe, Hiromi;
    • Kudo, Kenichiro;
    • Matsumoto, Shingo;
    • Umemura, Shigeki;
    • Goto, Koichi;
    • Ichihara, Eiki;
    • Ninomiya, Takashi;
    • Kubo, Toshio;
    • Sato, Akiko;
    • Hotta, Katsuyuki;
    • Tabata, Masahiro;
    • Toyooka, Shinichi;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    In this Issue.

    Published in:
    Cancer Science, 2018, v. 109, n. 10, p. 2996, doi. 10.1111/cas.13374
    Publication type:
    Article
    37

    Issue Information.

    Published in:
    Cancer Science, 2018, v. 109, n. 10, p. 2993, doi. 10.1111/cas.13373
    Publication type:
    Article